[Squamous cell carcinoma of the lung detected during maintenance hemodialysis which reduced in size after combined CDDP chemotherapy].

Abstract

A 52-year-old man receiving maintenance hemodialysis for 6 years was referred to our division for further evaluation and additional therapy for cough and hemosputum lasting 2 months, and for examination of a chest roentgenographic abnormality. Transbronchial lung biopsy specimens revealed squamous cell carcinoma of the lung. A total of 8 courses of anticancer chemotherapy with 25-30 mg/m2 of CDDP performed biweekly resulted in a partial remission (56%) but no side effects, including gastrointestinal damage and agranulocytosis. Few cases of lung cancer receiving anticancer chemotherapy with CDDP during maintenance hemodialysis have been reported. Administration methods and dosage of CDDP for patients receiving maintenance hemodialysis were discussed.

• Authors: S Umeki, M Wakunami, H Kawane, R Soegima
• Journal: Nihon Kyobu Shikkan Gakkai zasshi (Nihon Kyobu Shikkan Gakkai Zasshi) Vol. 28 Issue 9 Pg. 1225-9 (Sep 1990) ISSN: 0301-1542 [Print] Japan
• PMID: 2266629 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Cisplatin

Topics

• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Carcinoma, Squamous Cell (drug therapy, etiology, pathology)
• Cisplatin (administration & dosage)
• Humans
• Kidney Failure, Chronic (complications, therapy)
• Lung Neoplasms (drug therapy, etiology, pathology)
• Male
• Middle Aged
• Renal Dialysis